Low vitamin D level is an independent predictor of poor outcomes in Clostridium difficile-associated diarrhea

Therapeutic Advances in Gastroenterology

Volumn 7, Issue 1, 2014, Pages 14-19

  Wang, Wallace J ^a   Hussain, Syed A ^a   Kim, Sang H ^a   Mehta, Preeti ^a   Rubin, Moshe ^a   Gray, Sondra ^a   Arramraju, Sushma ^a   John, Bijo K ^a   Sison, Cristina ^b  

^a NEW YORK HOSPITAL QUEENS   (United States)

^b FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

Author keywords

clostridium difficile diarrhea; Clostridium difficile enteritis; hypovitaminosis D; recurrent clostridium difficile; vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; ALBUMIN; METRONIDAZOLE; VANCOMYCIN; VITAMIN D;

ADULT; AGE; AGED; ALBUMIN BLOOD LEVEL; ANTIBIOTIC THERAPY; ARTICLE; CHARLSON COMORBIDITY INDEX; CLOSTRIDIUM DIFFICILE INFECTION; COHORT ANALYSIS; COMORBIDITY; FEMALE; FOLLOW UP; GENDER; HOSPITAL PATIENT; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MIDDLE AGED; NURSING HOME; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENT DISEASE; VERY ELDERLY; VITAMIN BLOOD LEVEL;

EID: 84891137954     PISSN: 1756283X     EISSN: 17562648     Source Type: Journal    
DOI: 10.1177/1756283X13502838     Document Type: Article

References (21)

1. Alfa M. Harding G. Ronald A. Light R. MacFarlane N. Olson N. et al. (1999) Diarrhea recurrence in patients with Clostridium difficile associated diarrhea: role of concurrent antibiotics. Can J Infect Dis 10: 287–294.
2. Arnedo-Pena A. Juan-Cerdan J. Romeu-Garcia A. Garcia-Ferrer D. Holguin-Gomez R. Iborra-Millet J. et al. (2011) Latent tuberculosis infection, tuberculin skin test and vitamin D status in contacts of tuberculosis patients: a cross-sectional and case-control study. BMC Infect Dis 11: 349–357.
3. Cannell J. Vieth R. Umhau J. Holick M. Grant W. Madronich S. et al. (2006) Epidemic influenza and vitamin D. Epidemiol Infect 134: 1129–1140.
4. Cantorna M. Mahon B. (2004) Mounting evidence for vitamin D as an environmental factor affecting autoimmune disease prevalence. Exp Biol Med 229: 1136–1142
5. Charlson M. Pompei P. Ales K. Mackenzie C. (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis 40: 373–383.
6. Choi H. Kim K. Lee S. Lee S. (2011) Risk factors for recurrence of Clostridium difficile infection: effect of Vancomycin-resistant enterococci colonization. J Korean Med Sci 26: 859–864.
7. de Groot V. Beckerman H. Lankhorst G. Bouter L. (2003) How to measure comorbidity: a critical review of available methods. J Clin Epidemiol 56: 221–229.
8. Hewison M. (2012) Vitamin D and the immune system: new perspectives on an old theme. Rheum Dis Clin North Am 38: 125–139.
9. Kelly C. LaMont J. (2008) Clostridium difficile–more difficult than ever. N Engl J Med 359: 1932–1940.
10. Lucardo J. Gould C. Elixhauser A. (2012) Clostridium difficile infections in hospital stays, 2009. Healthcare Cost and Utilization Project Statistical Brief #124. US Department of Health and Human Services Agency for Healthcare Research and Quality. Available at: http://www.hcup-us.ahrq.gov/reports/statbriefs/sb124.pdf (accessed 3 May 2012).
11. McDonald L. Lessa F. Sievert D. Wise M. Herrera R. Gould C. et al. (2012) Vital signs: preventing Clostridium difficile infections. Morbid Mortal Weekly Rep 61: 157–162.
12. McFarland L. Elmer G. Surawicz C. (2002) Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease. Am J Gastroenterol 97: 1769–1775.
13. McFarland L. Surawicz C. Rubin M. Fekety R. Elmer G. Greenberg R. (1999) Recurrent Clostridium difficile disease: epidemiology and clinical characteristics. Infect Control Hosp Epidemiol 20: 43–50.
14. Melamed M. Michos E. Post W. Astor B. (2008) 25-hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med 168: 1629–1637.
15. O'Brien J. Lahue B. Caro J. Davidson D. (2007) The emerging infectious challenge of Clostridium difficile-associated disease in Massachusetts hospitals: clinical and economic consequences. Infect Control Hosp Epidemiol 28: 1219–1227.
16. Sanchez de la Torre M. Torres C. Nieto G. Vergara S. Carrero A. Macias J. et al. (2008) Vitamin D receptor gene haplotypes and susceptibility to HIV-1 infection in injection drug users. J Infect Dis 197: 405–410.
17. Talat N. Perry S. Parsonnet J. Dawood G. Hussain R. (2010) Vitamin D deficiency and tuberculosis progression. Emerg Infect Dis 16: 853–855.
18. Vesteinsdottir I. Gudlaugsdottir S. Einarsdottir R. Kalaitzakis E. Sigurdardottir O. Bjornsson E. (2012) Risk factors for Clostridium difficile toxin-positive diarrhea: a population-based prospective case-control study. Eur J Clin Microbiol Infect Dis 31: 2601–2610.
19. Wenisch J. Schmid D. Tucek G. Kuo H. Allerberger F. Michi V. et al. (2012) A prospective cohort study on hospital mortality due to Clostridium difficile infection. Infection 40: 479–484.
20. Wilcox M. Fawley W. Settle C. Davidson A. (1998) Recurrence of symptoms in Clostridium difficile infection–relapse or reinfection? J Hosp Infect 38: 93–100.
21. Youssef D. Bailey B. El Abbassi A. Copeland R. Adebonojo L. Manning T. et al. (2010) Healthcare costs of Staphylococcus aureus and Clostridium difficile infections in veterans: role of vitamin D deficiency. Epidemiol Infect 138: 1322–1327.